Get started
Author

Brittany L. Steimle

Observed name: Brittany Steimle
ORCID: 0000-0003-3638-8767
Observed ORCID: 0000-0003-3638-8767
OpenAlex ID: A5054693070
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models
2021 · Dina Schneider, Ying Xiong, et al. · Science Translational Medicine · 154
Fluorescence resonance energy transfer links membrane ferroportin, hephaestin but not ferroportin, amyloid precursor protein complex with iron efflux
2019 · Adrienne C. Dlouhy, Danielle K. Bailey, et al. · Journal of Biological Chemistry · 58
PDF
The solute carriers ZIP8 and ZIP14 regulate manganese accumulation in brain microvascular endothelial cells and control brain manganese levels
2019 · Brittany L. Steimle, Frances M. Smith, et al. · Journal of Biological Chemistry · 52
The Ferroxidase Hephaestin But Not Amyloid Precursor Protein is Required for Ferroportin-Supported Iron Efflux in Primary Hippocampal Neurons
2017 · Changyi Ji, Brittany L. Steimle, et al. · Cellular and Molecular Neurobiology · 50
Armored TGFβRIIDN ROR1-CAR T cells reject solid tumors and resist suppression by constitutively-expressed and treatment-induced TGFβ1
2024 · Tri Minh Tran, Bal Krishna Chand Thakuri, et al. · Journal for ImmunoTherapy of Cancer · 28
PDF
Calcium and the Ca-ATPase SPCA1 modulate plasma membrane abundance of ZIP8 and ZIP14 to regulate Mn(II) uptake in brain microvascular endothelial cells
2022 · Brittany L. Steimle, Danielle K. Bailey, et al. · Journal of Biological Chemistry · 15
PDF
Optimized tandem BCMA-specific CAR T cells designed to minimize tonic signaling and off-target toxicity
2026 · Xu Wang, Peirong Hu, et al. · Blood Immunology & Cellular Therapy · 1
209 Novel BCMA/GPRC5D dual-targeting CAR-T cells mitigate antigen escape with a favorable safety profile for multiple myeloma
2026 · Kun Luo, Peirong Hu, et al. · Journal for ImmunoTherapy of Cancer
PDF
292 Optimized bi-paratopic BCMA-specific CAR T cells designed to minimize tonic signaling and off-target toxicity
2025 · Xu Wang, Peirong Hu, et al. · Journal for ImmunoTherapy of Cancer
PDF
208 A novel fully human MSLN CAR armored with dominant negative TGFβ receptor II demonstrates enhanced efficacy in xenograft models of pancreatic cancer
2025 · Bal Krishna Chand Thakuri, Tri M Tran, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract 3184: Development of novel anti-mesothelin CAR-T cells for the treatment of solid tumors
2025 · Sayyed Hamid Zarkesh Esfahani, Kun Luo, et al. · Cancer Research
Abstract 2913: Co-expression of extracellular matrix enzymes heparanase or PH-20 augments the anti-tumor efficacy of folate receptor 1-targeting CAR T cells in an ovarian cancer model
2024 · Brittany L. Steimle, Peirong Hu, et al. · Cancer Research
280 Multiplex immunofluorescence imaging of armored CAR T cells in pancreatic ductal adenocarcinoma mouse xenografts confirms potent anti-tumor response
2023 · Jia-Jye Lee, Kathleen Baysac, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract 3198: Fully human CD20 and CD19 dual-targeting CAR-T cells mediate long-term remissions and protection from tumor rechallenge in vivo
2023 · Peirong Hu, Brittany Steimle, et al. · Cancer Research
287 Novel, boosted, fully human ROR1-targeting CAR T cells effectively eliminate hematologic and solid tumors, and resist tumor microenvironment
2022 · Tri Tran, Bal Krishna Chand Thakuri, et al. · Journal for ImmunoTherapy of Cancer
PDF
Works count: 15
Citation count: 358
H-index: 6
I10-index: 6
Year
Topic
Type